on DBV TECHNOLOGIES (EPA:DBV)
DBV Technologies publishes its 2026 Half-Year Financial Report
On July 16, 2026, DBV Technologies announced the publication of its 2026 Half-Year Financial Report. This report has been filed with the French Financial Markets Authority (AMF). The biotechnology company offers the opportunity to view or download this document on its website as well as on the AMF website.
DBV Technologies operates primarily in the food allergy treatment sector. It develops innovative solutions using its proprietary VIASKIN® patch technology. The company is listed on Euronext Paris and Nasdaq. Its headquarters are located in Châtillon, France, with operations in North America. For more information, please visit its online platforms.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all DBV TECHNOLOGIES news